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ANTIBODY CORRELATES OF VACCINE INDUCED PROTECTION AGAINST 
EBOLA VIRUS INFECTION IN NONHUMAN PRIMATES 
Sudil Mahendra and Nancy J. SuUivan* 
Biology Department, Illinois Wesleyan University, and 
The National Institutes of Health 
The Ebola virus is a single-stranded RNA virus that causes Ebola hemorrhagic fever. A vaccine 
candidate for the Ebola virus was developed in the lab of Dr. Nancy J. Sullivan at the National 
Institutes of Health using the wild-type Ebola surface glycoprotein (GP). However, due to 
concerns with in vitro cytotoxicity, a point mutant (PM) version of the GP vaccine was created. 
However, the PM GP vaccine lost a correlate of survival in the process; the IgG concentration in 
the blood serum of immunized non-human primates was no longer correlated with survival. We 
hypothesized that antibody avidity, a qualitative property, correlates with survival when ELISA 
IgG titers do not discern meaningful differences. We tested this hypothesis by measuring the 
avidity in sera from vaccinated macaques with a modified ELISA that compares antibody 
binding in the presence of urea. The avidity values measured did not provide a significant 
correlate of survival. 
